Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 15:12:820051.
doi: 10.3389/fphar.2021.820051. eCollection 2021.

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications

Affiliations
Editorial

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications

Roy L Soiza et al. Front Pharmacol. .
No abstract available

Keywords: anticholinergic; antimuscarinic; drug safety; medication withdrawal; medicines optimisation; prescribing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research TopicDeprescribing and Minimizing Use of Anticholinergic Medications

References

    1. Bostock C. V., Soiza R. L., Mangoni A. A. (2010) Association between Prescribing of Antimuscarinic Drugs and Antimuscarinic Adverse Effects in Older People. Expert Rev. Clin. Pharmacol. 3, 441–452. 10.1586/ecp.10.34 - DOI - PubMed
    1. Boustani M., Campbell N., Munger S., Maidment I., Fox C. (2008). Impact of Anticholinergics on the Aging Brain: a Review and Practical Application. Aging Health 4, 311–320. 10.2217/1745509X.4.3.311 - DOI
    1. Fox C., Smith T., Maidment I., Chan W. Y., Bua N., Myint P. K., et al. (2014). Effect of Medications with Anti-cholinergic Properties on Cognitive Function, Delirium, Physical Function and Mortality: a Systematic Review. Age Ageing 43, 604–615. 10.1093/ageing/afu096 - DOI - PubMed
    1. Hanlon P., Quinn T. J., Gallacher K. I., Myint P. K., Jani B. D., Nicholl B. I., et al. (2020). Assessing Risks of Polypharmacy Involving Medications with Anticholinergic Properties. Ann. Fam. Med. 18,148–155. 10.1370/afm.2501 - DOI - PMC - PubMed
    1. Lowry E., Woodman R. J., Soiza R. L., Mangoni A. A. (2011). Associations between the Anticholinergic Risk Scale Score and Physical Function: Potential Implications for Adverse Outcomes in Older Hospitalized Patients. J. Am. Med. Dir. Assoc. 12, 565–572. 10.1016/j.jamda.2011.03.006 - DOI - PubMed

Publication types

LinkOut - more resources